1. Introduction {#s0005}
===============

The central nervous system is an early target of HIV infection ([@bb0010]). Along those lines, a multitude of studies have used MR volumetry in the assessment of HIV-positive (HIV +) patients, showing various levels of volume loss ([@bb0025], [@bb0055], [@bb0085], [@bb0095]), reflective of HIV-associated neurodegeneration. Even in the post-antiretroviral therapy (ART) era, brain volume loss remains prevalent and progressive, suggesting ongoing brain injury ([@bb0055], [@bb0035]).

As in humans, brain morphology is often an important biomarker of neuropathology in animal models of neurodegeneration ([@bb0330]). The HIV-1 transgenic (Tg) rat model is a popular small animal model in NeuroHIV studies, is known to develop neurological abnormalities with age and has been proposed as a model of chronic HIV infection in the post-ART era ([@bb0290], [@bb0285], [@bb0175], [@bb0305], [@bb0220]). In this model, the transgene expresses 7 of the 9 HIV genes (including gp120, nef, and tat) and neurologic damage is assumed to result from chronic exposure to neurotoxic effects of viral proteins ([@bb0290], [@bb0205], [@bb0225]). We have previously described structural and functional abnormalities in the Tg rat in comparison to age-matched wild type (WT) rats ([@bb0130], [@bb0135], [@bb0140]) as well as defective exploratory and motor behavior ([@bb0230]). The latter (neurobehavioral deficits) were assessed using a combination of open field box (measuring total exploratory activity, distances traveled in the internal and external zones, number of line crossings, rearing time and rearing time in the external zone) reflective of general locomotor activity, unconditioned motivated behavior, and behavioral plasticity ([@bb0295]) and accelerating rotarod apparatus (measuring the latency to fall detected by a photo-beam under the rotating shaft) reflective of motor learning/planning and locomotor activity ([@bb0245]).

Besides cross-sectional detection of brain volume discrepancies in the young and old Tg rats compared to WT rats, a main aim in this study was to longitudinally evaluate brain growth rates in both groups to better understand the dynamics of brain injury in the Tg rat and to document the earliest time point at which brain injury starts. Towards this goal, we used volumetric MR as a biomarker of neuropathology. We then correlated with concurrently obtained neurobehavioral testing measures that were previously used and reported in correlation with FDG PET imaging ([@bb0230]). We also wanted to assess the growth rates of various brain subregions compared to the whole brain, since we suspected differential regional vulnerabilities to viral protein toxicity.

2. Materials and methods {#s0010}
========================

2.1. Animals {#s0015}
------------

Male HIV-1 Tg rats (F344/Hsd) and age-matched WT rats (F344) were purchased from Envigo (Indianapolis, IN) and used in various experiments. All rats were housed in a temperature-controlled environment with a 12-h light/dark cycle and free access to food and water. All procedures were conducted during the light cycle and all neurobehavioral tests were performed between 10 AM and 2 PM. All studies were approved by the Animal Care and Use Committee of the National Institutes of Health, Clinical Center.

2.2. In vivo MRI acquisition {#s0020}
----------------------------

MR images were acquired using a PharmaScan 7T/16 Scanner (Bruker, Germany). Rats were anesthetized with 1--2.5% isoflurane using a vaporizer and a facial mask. A heating pad was wrapped around the rat cradle for maintenance of physiological body temperature. For the cross-sectional study (*n* = 20), rats were divided into four cohorts: young Tg (*n* = 6, age = 3.6 ± 0.13 months), young WT (*n* = 4, age = 3.6 ± 0.12 months), old Tg (*n* = 5, age = 19.2 ± 0.10 months), and old WT (*n* = 5, age = 18.4 ± 0.05 months). A cross-coil setup was used which included a 72 mm transmission coil and a 20 mm surface coil placed on the animal\'s head. A series of sagittal T2-weighted images (rapid acquisition with refocused echoes, RARE) were initially obtained at the midline to allow for consistent positioning of the coronal images with respect to the corpus callosum. Parameters included echo time (TE) = 49 ms, repetition time (TR) = 1000 ms, slice thickness = 0.5 mm, matrix size = 256 × 256, field of view (FOV) = 35 × 35 mm (spatial resolution = 0.14 × 0.14 mm/pixel) and 8 averages. T2-weighted images for the segmentation portion of this study were acquired in the coronal plane. Parameters included: TE/TR = 12.3/3379 ms, slice thickness = 1 mm and RARE factor of 8 (image acquisition time \~ 15 min).

For the longitudinal study, MRI scans were obtained on 5 male Tg and 4 age-matched WT rats. The first MR acquisition was performed at 5 weeks of age, then every 4 weeks with the last time point acquired at 23 weeks of age. A 9 cm RF birdcage volumetric coil was used for image acquisition. Parameters for 3-dimensional (3D) T2-weighted fast spin echo included: TE/TR = 84/1000 ms, slice thickness = 0.312 mm, FOV = 40 × 40 × 40 mm, and matrix size: 128 × 128 × 128 (spatial resolution = 0.312 × 0.312 × 0.312 mm/pixel), flip angle = 180°, echo train length = 16 and 4 averages with image acquisition time of \~ 68 min. Images were post processed to matrix of 256 × 256 × 256 resulting in isotropic resolution of 0.156 mm. The animals\' weights were recorded at each time point.

2.3. Image analysis {#s0025}
-------------------

For the cross-sectional images, we used manual segmentation of whole brain volumes using the "Levelset VOI" and "Paint brush" tools in MIPAV (Medical Image Processing, Analysis, and Visualization), a free software developed at NIH.

For the longitudinal images, MIPAV was used for rigid alignment of all images (9 animals × 5 timepoints = 45 scans) to the same target space. Each image was segmented by registration of multiple atlases followed by manual refinement. An image template and atlas were created for each time point (5, 9, 13, 17, 23 weeks) and for each genotype (WT/Tg) (total of ten templates). Templates were created by averaging the MRI images for each subgroup. Nine volumes of interest were then delineated to create an atlas using ITK-Snap: whole brain, which includes CSF and parenchyma, striatum, corpus callosum, hippocampus, cortex, cerebellum, olfactory bulbs, brainstem, and ventricles. Segmentations were based on Paxinos and Watson rat brain atlas ([@bb0200]). Whole brain label propagation was used for skull stripping before subregional segmentation.

The multi-atlas image segmentation method was performed using affine registration of multiple atlases to each individual target ([@bb0020], [@bb0045]). Afterwards, higher probability rules/majority voting and manual input determined pixel classification for each subregion ([@bb0155]). For ventricular segmentation, we used a combination of multi-atlas based segmentation and intensity thresholding.

2.4. Neurobehavioral testing {#s0030}
----------------------------

The neurobehavioral data included in this paper has been previously reported in correlation with FDG PET imaging in the same group of rats ([@bb0230]). As previously described, neurobehavioral testing was performed longitudinally. Data on changes in motor function from Tg and WT rats was collected using a Rota-rod apparatus, operated in an accelerated mode (Med Associates, Inc., St. Albans, VT). Rats were tested starting at 5 weeks of age, with each time point consisting of 2 trials (total of thirteen time points, over a period of 16 weeks). The rota-rod has a default speed of 4 rpm and accelerates to 40 rpm over the 5 min testing period. Once a rat was removed from its cage, it was placed on the rod in the direction of rotation. A photo-beam under the rotating shaft detected when the animal had fallen and data was collected on the latency to fall.

Exploratory activity in the same group of animals was assessed using open field testing. The apparatus (ANY-maze, Stoelting Co., Wood Dale, IL) has a square floor with side lengths of 40 cm, surrounded by 35 cm high opaque Plexiglas walls, an overhead recording camera, photo-beam array (to detect rearing behavior) and tracking software (used for tracking and analyzing data in pre-defined zones). All trials were conducted at the same time of the day (10 AM--2 PM) at 30 min intervals. Under low illumination, tracking was initiated once the animal was placed in the center of the field. Tests were started when the animals were 11 week-old and seven time points were collected over 14 weeks. Total exploratory activity scores were collected for analysis and correlation with brain volumetry. We chose the total exploratory activity score since it mirrors the 6 min walk test, a clinical outcome measure to assess locomotive activity and coordination in small animals ([@bb0075], [@bb0265]).

2.5. Statistical analysis {#s0035}
-------------------------

### 2.5.1. Brain volume differences {#s0040}

For cross-sectional images, differences between Tg and WT animals and between young and old rats were assessed by analysis of variance (ANOVA). If the ANOVA was deemed significant, Student\'s *t*-tests were then performed.

In the longitudinal study, statistical analysis of brain volumes (total and subregional) was performed using mixed models with repeated measures (SAS/STAT Software 9.4, SAS Institute, Inc., Cary, NC). For modeling separate subregions as well as the whole brain, two predictor variables, genotype and age, were included, as well as their interaction.

Based on these models, we compared whole brain and subregional volume in Tg and WT rats at each time point and assessed the percent decrease in Tg brain volumes using the WT volumes as reference. Additionally, whole brain and subregional growth rates (μl/week) were calculated for Tg and WT rats separately (slopes of growth rates between 5 and 9 weeks, between 9 and 13 weeks, between 13 and 17 weeks and between 17 and 23 weeks) and were compared using least squares means estimate model for assessment of differences in slopes.

### 2.5.2. Body weight differences {#s0045}

Using the same approach as with brain volumes, mixed models with repeated measures were used to compare WT and Tg rat weights at each time point. Group, age and group by age interaction were assessed. Additionally, body weight growth rates (g/week) between the imaging time points were compared between the two genotypes.

### 2.5.3. Predictive models of neurobehavioral performance {#s0050}

Brain volume measurements were interpolated for weeks where imaging and behavioral studies did not overlap. Using the segmented data as sample points, data interpolation was performed using a shape-preserving piecewise cubic interpolation. The interpolated value is based on neighborhood grid points. Data was interpolated for a range of 4 to 25 weeks.

We then explored the association between rota-rod performance and several factors: whole-brain volume, genotype (Tg versus WT), age (as well as squared and cubed) and weight (as well as squared and cubed). A repeated-measures mixed model was applied with the rota-rod performance score as the dependent variable (Y-variable) and the factors listed above as potential predictors (X-variables). The "best" model was selected based on the Bayesian Information Criterion (BIC), a criterion for model selection among a finite set of models. Predictors from the best model are reported with their corresponding significant *p*-value. This analysis was repeated 8 times, with the whole-brain volume replaced with the volume of each of the 8 brain subregions. The same approach was used to evaluate the association between total exploratory activity and the factors listed above by replacing rota-rod performance score with total exploratory behavior score as the dependent variable and repeating the analysis. The statistical significance of each predictor variable in the "best" model was then examined for significance (*p* \< 0.05). *P*-values \< 0.05 were considered statistically significant, although because of multiplicity, *p*-values between 0.01 and 0.05 should be viewed as borderline significant.

3. Results {#s0055}
==========

3.1. Cross sectional and longitudinal brain volume differences {#s0060}
--------------------------------------------------------------

In the cross-sectional analysis, the HIV-1 Tg rats were found to have smaller WB volumes when compared to age-matched WT rats in both age groups ([Table 1](#t0005){ref-type="table"}). In the young cohorts, Tg whole brain volumes were 9.6% smaller than WT on average, while in the old cohort, the Tg brain volumes were 10.3% smaller. Those differences were highly significant. Larger WB volumes were also seen in the older cohorts compared to younger cohorts in both animal groups (Tg and WT).Table 1Cross-sectional comparison of whole brain volumes (μl) in the Tg and WT rats.Table 1GroupAge (months)Volume (μl)ANOVA[⁎](#tf0005){ref-type="table-fn"}Group comparisons*P* values[⁎⁎](#tf0010){ref-type="table-fn"}Young Tg (*n* = 6)3.6 ± 0.131855 ± 75.4*p* \< 0.0001Young Tg vs young WT0.001Young WT (*n* = 4)3.6 ± 0.122051 ± 36.5Old Tg vs old WT0.0001Old Tg (*n* = 5)19.2 ± 0.102046 ± 42.1Young Tg vs old Tg0.0001Old WT (*n* = 5)18.4 ± 0.052282 ± 51.6Young WT vs old WT0.001[^1][^2][^3][^4]

For the longitudinal analysis, whole brain volumes of Tg rats were significantly decreased compared to age-matched WT rats at all ages ([Fig. 2](#f0010){ref-type="fig"}) with [Table 2](#t0010){ref-type="table"} showing the statistical significance of the Genotype and Age effects: \[Genotype: F (1, 9) = 142.71, *p* \< 0.0001; Age: F (4, 27) = 249.04, *p* \< 0.0001\]. The subregional volume differences however did not exactly match those in the whole brain. This was most noticeable in the striatum which showed 25--28% decreased volume compared to only 9--12% decreased whole brain volume ([Table 2](#t0010){ref-type="table"}). When we compared the growth rate slopes of the Tg and WT rats between the different imaging time points, we found that growth rates between the two groups differed significantly for whole brain and all subregions (except ventricles) between 5 and 9 weeks. Growth rates were not significantly different beyond 9 weeks of age ([Table 3](#t0015){ref-type="table"}). When assessing the various regions, the delay in striatal growth was more appreciable (48% lower in Tg compared to WT) than that of whole brain (27% lower in Tg compared to WT) and all other regions ([Table 3](#t0015){ref-type="table"}). It also was disproportionate to the rate of change of body weight (15% delay in body growth in Tg compared to WT) ([Table 3](#t0015){ref-type="table"}).Table 2Longitudinal whole brain and regional volume and body weight differences between WT and Tg rats (WT \> Tg).Table 2Imaging time pointsGenotype effectsAge effects5 weeks9 weeks13 weeks17 weeks23 weeksPr \> F (DF)Pr \> F (DF)Whole brain9%12%12%11%11%\< 0.0001 (9)\< 0.0001 (27)Striatum25%28%27%28%27%\< 0.0001 (7)\< 0.0001 (28)Corpus callosum19%21%22%23%22%\< 0.0001 (9)\< 0.0001 (28)Hippocampus15%17%17%18%16%\< 0.0001(7)\< 0.0001(28)Cortex12%15%15%15%15%\< 0.0001 (9)\< 0.0001 (28)Cerebellum6%9%9%9%9%\< 0.0001 (10)\< 0.0001 (28)Olfactory bulb6%8%7%8%8%\< 0.0001 (7)\< 0.0001 (28)Brainstem7%11%10%10%10%0.0003 (7)\< 0.0001 (25)Ventricles− 14%− 15%− 14%− 13%− 11%\< 0.0001 (7)\< 0.0001 (28)Body weight− 3%7%10%13%14%0.0153 (11)\< 0.0001 (28)[^5][^6]Table 3Whole brain and regional volume growth rates (μl/week) and rates of change in body weight (g/week) for WT and Tg rats (WT \> Tg) across various time points.Table 3From 5 to 9 weeksFrom 9 to 13 weeksFrom 13 to 17 weeksFrom 17 to 23 weeksTgWTDiff. (DF)*P*-value% differenceTgWTDiff. (DF)TgWTDiff. (DF)TgWTDiff. (DF)Whole brain62.4285.5623.14 (27)0.001627%24.6826.92.22 (27)20.5921.40.81 (27)15.615.12− 0.47 (27)Striatum1.162.241.08 (28)\< 0.000148%0.570.49− 0.08 (28)0.390.750.36 (28)0.20.14− 0.06 (28)Corpus callosum1.642.420.78 (27)0.000532%0.50.780.28 (27)0.520.790.27 (27)0.310.28− 0.03 (27)Hippocampus1.482.120.64 (28)0.002330%0.520.630.11 (28)0.490.680.20 (28)0.180.03− 0.15 (28)Cortex12.2318.66.37 (27)0.001534%4.824.74− 0.08 (27)4.155.831.68 (27)1.611.650.04 (27)Cerebellum9.95133.05 (27)0.00223%3.283.810.53 (27)2.532.730.20 (27)1.240.96− 0.29 (27)Olfactory bulb6.698.111.42 (28)0.04618%2.392.18− 0.21 (28)2.072.420.36 (28)0.430.690.26 (28)Brainstem4.636.611.99 (25)0.01530%2.171.71− 0.46 (25)1.31.790.48 (25)0.660.790.12 (25)Ventricles1.351.16− 0.18 (28)\> 0.05− 16%0.460.45− 0.01 (28)0.150.240.09 (28)0.270.350.07 (28)Body weight24.65294.35 (28)0.01315%11.0713.922.85 (28)9.2212.463.24 (28)5.527.441.92 (28)[^7][^8][^9]

3.2. Weight differences {#s0065}
-----------------------

We started our imaging and behavioral studies at the age of 5 weeks at which point the body weights of Tg and WT rats were similar \[WT mean weight: 86.9 ± 6.94 g, Tg mean weight: 89.4 ± 10.42 g\] ([Fig. 1](#f0005){ref-type="fig"}). The Tg rat weights however started diverging from WT weights (Tg \< WT) and the differences became significantly different at and after 13 weeks of age \[F (1, 10.6) = 5.36, *p* \< 0.05\]. Overall, Tg rats weighed significantly less compared to age-matched WT rats with significant group and age effects as well as group by age effect \[Transgene: F (1, 11.1) = 8.19, *p* \< 0.02; Age: F (4, 28) = 1614.19, *p* \< 0.0001; Interaction: F (4, 28) = 20.15, *p* \< 0.0001\]. While the rate of change in body weight was higher in the WT compared to Tg rats across the various time points, the difference between the slopes was statistically significant only between 5 and 9 weeks ([Table 3](#t0015){ref-type="table"}).Fig. 1Longitudinal weight changes of Tg and WT rats over time.Fig. 1Fig. 2Longitudinal whole brain and regional volume changes of Tg and WT rats over time.Fig. 2Fig. 3A, MRI scans of one WT rat and one Tg rat at 5 and 23 weeks of age. The third column shows the overlap between the scans. Note slight prominence of the ventricles in the Tg rat at 23 weeks of age (white arrows). B, 3-Dimensional rendering (lateral view) of mean WT and Tg rat brain volumes (in blue and red respectively) at 5 weeks and 23 weeks. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 3

3.3. Analysis of neurobehavioral performance and brain volumes {#s0070}
--------------------------------------------------------------

### 3.3.1. Rota-rod performance {#s0075}

As previously reported, the WT rats significantly outperformed the Tg rats on the rota-rod ([@bb0230]). Of the multiple explanatory variables considered (whole brain/subregional volumes (analyzed separately), genotype, weight, and age), genotype and weight were generally found to be the "best" set of predictors of rota-rod performance based on BIC ([Table 4](#t0020){ref-type="table"}), with *p*-values of 0.016 and \< 0.0001, respectively, except for the striatum. For the latter, the combination of striatal volume (*p* \< 0.0001) and genotype (*p* \< 0.0001) was instead found to be the "best" set of predictors rather than genotype and weight as for the other subregions.Table 4Predictive models of neurobehavioral performance/rota-rod score.Table 4Y-variable = rotarod scoreVolumetric X-variable consideredBest model includes (X-variables selected)*P* values (DF)[⁎](#tf0015){ref-type="table-fn"}Whole brain volumeGenotype & weight0.016 (8), \< 0.0001 (98)Striatum volumeGenotype & striatum volume\< 0.0001 (26), \< 0.0001 (98)Corpus callosum volumeGenotype & weight0.016 (8), \< 0.0001 (98)Hippocampus volumeGenotype & weight0.016 (8), \< 0.0001 (98)Cortex volumeGenotype & weight0.016 (8), \< 0.0001 (98)Cerebellum volumeGenotype & weight0.016(8), \< 0.0001 (98)Olfactory bulb volumeGenotype & weight0.016 (8), \< 0.0001 (98)Brainstem volumeGenotype & weight0.016 (8), \< 0.0001 (98)Ventricles volumeGenotype & weight0.016(8), \< 0.0001 (98)[^10]

It\'s worth noting that for the whole brain measurements, the next best model after genotype and weight (based on BIC) was the combination of whole brain volume (*p* = 0.023) and weight (*p* \< 0.0001).

### 3.3.2. Total exploratory activity score {#s0080}

Similarly, in the open field test, the WT rats significantly outperformed the Tg rats ([@bb0230]). When considering the total exploratory activity score, the combination of genotype and weight again best predicted performance \[Genotype: *p* = 0.007, Weight: *p* \< 0.0001\] based on the mixed linear models with the lowest BIC, when whole brain volume was included among the explanatory variables. For the striatum, the combination of striatal volume (*p* = 0.038), genotype (*p* = 0.011) and age (*p* = 0.015), was found to be the most predictive based on the mixed linear models with lowest BIC ([Table 5](#t0025){ref-type="table"}). For the rest of the subregions, various results were seen. When the cerebellum volume was considered, the best set of predictors were the cerebellum volume (*p* = 0.034), genotype (*p* = 0.003) and age (*p* = 0.027). When the olfactory bulbs volume was considered, the best set of predictors included all 4 factors: olfactory bulbs volume (*p* \< 0.0001), genotype (*p* \< 0.0001), age (*p* \< 0.0001) and weight (*p* = 0.003). For the rest of the subregions (hippocampus, brainstem, cortex, corpus callosum, and ventricles) considered individually, the same combination of factors as for the whole brain volume (genotype and weight with same *p*-values) was found to be best predictor of the total exploratory activity score.Table 5Predictive models of neurobehavioral performance/total exploratory activity score.Table 5Y-variable = open field score (total exploratory activity score)Volumetric X-variable consideredBest model includes (X-variables included)*P* values (DF)[⁎](#tf0020){ref-type="table-fn"}Whole brain volumeGenotype & weight0.007 (9), \< 0.0001(56)Striatum volumeGenotype, age & striatum volume0.011(58), 0.015(63), 0.038(61)Corpus callosum volumeGenotype & weight0.007 (9), \< 0.0001 (56)Hippocampus volumeGenotype & weight0.007 (9), \< 0.0001 (56)Cortex volumeGenotype & weight0.007 (9), \< 0.0001 (56)Cerebellum volumeGenotype, age & cerebellum volume0.003 (34), 0.027 (63), 0.034 (62)Olfactory bulb volumeGenotype, age, weight & olfactory bulb volume\< 0.0001 (63), \< 0.0001 (63), 0.003 (63), \< 0.0001 (63)Brainstem volumeGenotype & weight0.007 (9), \< 0.0001 (56)Ventricles volumeGenotype & weight0.007 (9), \< 0.0001 (56)[^11]

4. Discussion {#s0085}
=============

The neurologic manifestations of HIV infection include impairment of neurocognitive function ([@bb0005], [@bb0015]), abnormal cerebral blood flow ([@bb0260], [@bb0270]) and accelerated signs of aging ([@bb0210]). While the introduction of combination anti-retroviral therapy (cART) has significantly halted and controlled the infection itself, the neuropathology at the root of persistent and apparently progressive neurological damage in HIV remains incompletely understood ([@bb0105]). Using MR volumetric measurements, brain atrophy suggestive of neuronal injury has been repeatedly documented in HIV + patients, both in the pre and post-ART eras ([@bb0025], [@bb0055], [@bb0095], [@bb0035], [@bb0030]). Along those lines, we were interested in using MR volumetry to evaluate volume loss in the HIV-1 Tg rat, a model of viral protein induced neurotoxicity and of treated HIV + patients ([@bb0290], [@bb0205]).

Our preliminary cross-sectional MR volumetric measurements of the whole brain showed significantly smaller brain volumes in Tg rats compared to WT rats both at 3 and at 19 months of age ([Table 1](#t0005){ref-type="table"}). Based on those findings, we further evaluated brain and subregional volume differences in Tg and WT rats, using 3D MR imaging, longitudinally, in order to better understand the dynamics of Tg brain injury and to document the earliest time point at which damage starts. Interestingly, we were able to document smaller whole brain and subregional brain volumes in the Tg compared to age-matched WT rats, as early as 5 weeks of age (the youngest animals we could obtain commercially) despite the animals having similar weights at that time point ([Fig. 1](#f0005){ref-type="fig"} and [Table 2](#t0010){ref-type="table"}). Considering there are known correlations between brain volume and corresponding rat body weights ([@bb0275]), smaller brain volumes in the young Tg rat with comparable body weights suggested to us a neuropathology that is independent from weight/body growth. This neuropathology could be associated with the transgene expression of various viral proteins in the brain of the rats, which we have shown previously ([@bb0235]). The findings also demonstrate a rather early nature of brain injury in this animal model. This injury continued as the animals grew older, with worsening of volumetric discrepancies until 9 weeks of age, but not thereafter. The delays in brain and body growth rates in Tg compared to WT rats were also significantly different between 5 and 9 weeks but not beyond 9 weeks of age. Those findings suggest that the bulk of injury happens early on in those animals, and that by around 2.5 months of age, the pathology becomes stable and possibly irreversible.

Interestingly, many individual brain subregions showed larger volume discrepancies and growth rate delays when compared to whole brain volume between 5 and 9 weeks of age ([Table 3](#t0015){ref-type="table"}). Even though this would seem odd since the subregions we evaluated encompassed most of the brain parenchyma, it is however explainable by concomitant increased size of the ventricles accounting for apparently less impressive whole brain volume loss ([Fig. 3](#f0015){ref-type="fig"}). For example, at 9 weeks of age, while the Tg whole brain volume was 12% smaller than WT brain, the striatal volume was 28% smaller, the corpus callosum was 21% smaller and the ventricles were 13% larger ([Table 2](#t0010){ref-type="table"}). Among the various subregions, the one showing the biggest volume discrepancy and greatest growth rate difference between 5 and 9 weeks of age was the striatum.

In order to establish how predictive our volumetric measures were of previously reported neurobehavioral performance of the rats \[rota-rod and open field testing (total exploratory behavior)\] ([@bb0230]), we used repeated-measures mixed models, with the explanatory variables (x-variables) including genotype, age and weight in addition to the individual brain volumes (whole brain and each subregion were evaluated individually, not in combination). Even though the most predictive combination for whole brain and most subregions were genotype and age, the striatum stood out: striatal volume combined with genotype was the most predictive of rota-rod performance and the combination of striatal volume with genotype and age was the most predictive of total exploratory activity scores ([Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}). Those findings are consistent with our previous findings of dopaminergic dysfunction/loss in this animal model, using PET imaging ([@bb0130]) and with previous reports of poor learning of HIV Tg rats in the water maze task ([@bb0280]), which were typically thought to be dependent on the hippocampus but then proven to rather depend on the dorsal striatum and medial prefrontal cortex ([@bb0315]). This is also in line with previous reports of dopaminergic dysfunction in the Tg rats ([@bb0305], [@bb0180], [@bb0170], [@bb0250]) which probably parallels known susceptibility of the dopaminergic system to HIV in infected patients ([@bb0115], [@bb0110], [@bb0065], [@bb0070]). It again draws attention to the compounding effects of addiction drugs on a system that is already compromised, with worse damage seen in the Tg rats compared to WT rats under the effect of nicotine ([@bb0325], [@bb0320], [@bb0255], [@bb0050], [@bb0185]), ethanol ([@bb0310], [@bb0240]), methamphetamine ([@bb0170], [@bb0195], [@bb0080], [@bb0100], [@bb0150]) or cocaine administration ([@bb0180], [@bb0165]).

Interestingly, despite the volumetric discrepancies between our Tg and WT rats, we failed previously to detect any significant differences in glucose metabolism by FDG-PET imaging in the same group of animals ([@bb0230]). This could potentially reflect relatively preserved neuronal metabolic activity in this animal model while other cells with lower glucose metabolic rates undergo degeneration with secondary brain volume loss. This is consistent with our findings of severe astrocytic loss worsening with age ([@bb0235]). The exact cause of astrocytic vulnerability is still unclear although exposure to toxic viral proteins seems to be the most likely culprit. In fact we have previously shown expression of gp120 in the CSF of the Tg rats, which sometimes was higher than gp120 levels in the serum, as well as mRNA expression of gp120, nef and tat in the brain tissues, suggesting local production of viral proteins through transgene expression ([@bb0235]). This is presumably similar to the neuropathology observed in optimally-treated HIV + patients, in whom integrated HIV provirus within latently infected cells is believed to produce neurotoxic HIV viral proteins with detectable levels of tat in the CSF ([@bb0090]). Premature aging in the HIV + subjects ([@bb0210]) can thus be simulated by the premature aging of the Tg rats ([@bb0290]).

One limitation to our cross-sectional study is the use of 2D rather than 3D imaging sequences which made segmentation of the subregions difficult and inaccurate. This is why for the longitudinal scans we acquired 3D images (despite longer imaging times), allowing for individual regional segmentation in a more accurate manner. Another limitation is the fact that imaging and neurobehavioral testing were not performed on the same days, which eventually required interpolation of certain data points. This however was necessitated by the logistics of scanner availability, the need to perform all the neurobehavioral testing procedures at the same time of the day (10 AM--2 PM), and to allow the rats to rest and recover after undergoing anesthesia during MR scanning.

The use of dedicated small animal MRI scanners for depiction of volumetric abnormalities in animal models of neurodegeneration is a powerful modality that provides noninvasive imaging biomarkers of diseases such as Alzheimer\'s dementia, Rett syndrome and Schizophrenia ([@bb0040], [@bb0125], [@bb0300], [@bb0160], [@bb0215]). In many of those studies, behavioral deficits are often assessed concurrently and then correlated with brain volumes ([@bb0330], [@bb0215]). With the current increased availability of sophisticated segmentation techniques ([@bb0045], [@bb0275], [@bb0190], [@bb0120], [@bb0145], [@bb0060]) and the expansion of the use of structural high resolution MR imaging, brain volumetric biomarkers will allow better understanding of the mechanisms of disease and more importantly the effect of therapeutic and preventative approaches in neurodegenerative disorders. Whether MR brain volumetry can eventually be used as a biomarker of drug effects and therapeutic interventions in the HIV Tg rat remains to be seen.

In conclusion, using noninvasive MR imaging, we have shown brain volume discrepancies and neurobehavioral deficits in the Tg rat as early as 5 weeks of age, suggesting an early injury, which kept progressing until the age of 9 weeks, stabilizing afterwards. Based on those findings, if neuroprotective therapies are to be used in this model, we believe they should be applied at this early stage in order to halt the injury before longstanding structural changes become more entrenched and difficult to reverse. Therapies that manage to halt brain growth delay and volume discrepancies could then be further tested in translational human applications. We have also shown that striatal volumes along with different combinations of genotype and weight best predicted neurobehavioral deficits in this model, again pointing towards the special vulnerability of the dopaminergic system to viral protein toxicity. This is consistent with striatal volume being the most affected and striatal growth rate between 5 and 9 weeks of age being the most delayed among the subregions in the Tg compared to age-matched WT rats. Further evaluation of this animal model should concentrate on the striatum and the dopaminergic system to better understand the neuropathology and eventually extrapolate to human studies.
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[^1]: a\. Whole brain values include CSF in the ventricles and subarachnoid spaces.

[^2]: b\. Age and volumes are listed as mean ± standard deviation and units are μl.

[^3]: Overall *p*-value from ANOVA model with whole brain volume as response variable (y-variable) and genotype and age category as explanatory variables (x-variables).

[^4]: *P*-values from specific-group contrasts based on the ANOVA model.

[^5]: a\. (Pr \> F) is the *p* value based on F-test from the statistical repeated-measures model with two factors (genotype and age) and their interaction term.

[^6]: b\. DF represents the denominator degrees of freedom.

[^7]: a\. (DF) represents the denominator degrees of freedom.

[^8]: b\. % difference is calculated with respect to WT rats

[^9]: c\. *P*-values and % differences are only included for the 5--9 weeks age range. For the other age ranges, the differences in growth and body weight change rates were not significant.

[^10]: *P*-values are based on F-test from ANCOVA models. DF represents the denominator degrees of freedom.

[^11]: *P*-values are based on F-test from ANCOVA models. DF represents the denominator degrees of freedom.
